Monitoring, Prevention, and Provider Guidance: Building a Bone-Smart Plan Patients starting or continuing GLP-1 therapy should discuss baseline BMD screening (via DEXA scan or similar) with their provider, particularly if age 65+, postmenopausal, or have risk factors
Keep the medication in its original packaging if possible
This enables tumor-selective accumulation of ferroptosis-inducing payloads while minimizing off-target effects
Gobburu, Jogarao V
Once reconstituted, store at 2-8 C and plan around a roughly 28-day window unless the supplier gives stricter data
Alexis Pedrick: This is Laura Dawes, a historian of science and author of Childhood Obesity in America: An Epidemic. Laura Dawes: So in the way that genetics is the cool area now, or your microbiome, in the 1890s, endocrinology, that was it, that was the frontier of medicine